| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |